Skip to main content

Peer Review reports

From: Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

Original Submission
27 Jun 2023 Submitted Original manuscript
26 Jul 2023 Reviewed Reviewer Report
13 Aug 2023 Reviewed Reviewer Report
18 Sep 2023 Reviewed Reviewer Report
11 Nov 2023 Author responded Author comments - Liuting Zeng
Resubmission - Version 2
11 Nov 2023 Submitted Manuscript version 2
13 Nov 2023 Reviewed Reviewer Report
26 Nov 2023 Reviewed Reviewer Report
27 Nov 2023 Reviewed Reviewer Report
14 Dec 2023 Author responded Author comments - Liuting Zeng
Resubmission - Version 3
14 Dec 2023 Submitted Manuscript version 3
20 Dec 2023 Author responded Author comments - Liuting Zeng
Resubmission - Version 4
20 Dec 2023 Submitted Manuscript version 4
25 Dec 2023 Author responded Author comments - Liuting Zeng
Resubmission - Version 5
25 Dec 2023 Submitted Manuscript version 5
14 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Reviewed Reviewer Report
2 Feb 2024 Author responded Author comments - Liuting Zeng
Resubmission - Version 6
2 Feb 2024 Submitted Manuscript version 6
8 Feb 2024 Author responded Author comments - Liuting Zeng
Resubmission - Version 7
8 Feb 2024 Submitted Manuscript version 7
Publishing
13 Feb 2024 Editorially accepted
13 Mar 2024 Article published 10.1186/s12916-024-03303-4

You can find further information about peer review here.

Back to article page